- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01711944
Online Problem Solving Skills Training
Online Implementation of Problem Solving Skills Training for Mothers of Newly Diagnosed Childhood Cancer Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Los Angeles, California, United States, 90027-6016
- Children's Hospital Los Angeles
-
-
New York
-
Rochester, New York, United States, 14642
- University of Rochester Medical Center
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15213
- Children's Hospital of Pittsburgh
-
-
Tennessee
-
Memphis, Tennessee, United States, 38105-3678
- St. Jude Children's Research Hospital
-
-
Texas
-
Houston, Texas, United States, 77030
- Texas Children's Hospital
-
Houston, Texas, United States, 77030
- University of Texas/MD Anderson Cancer Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria: Subjects will be drawn from the pool of all parents who are primary caregivers of children diagnosed with any form of cancer 4-16 weeks prior to contact about the Problem Solving Skills Training intervention and cared for at one of the 4 data collection sites. No attempt will be made to stratify the sample by any particular demographic variables (e.g., age, ethnic background, or type of cancer diagnosed in their child), except that monolingual Spanish-speaking parents will be specifically recruited to provide adequate representation for statistical analysis at Childrens Hospital Los Angeles and UT/MD Anderson Cancer Center. Goal: 20% total enrollment.
Exclusion Criteria: Parents of children with cancer will be excluded if (1) they do not read or speak English or Spanish; (2) their child is in severe a medical crisis, as determined by the oncologist, or (3) they live a prohibitive distance to complete the intervention (typically, >50 miles from the Center) and do not have access to a telephone for phone intervention sessions. Internet access will be facilitated as part of the e-PSST intervention arm. These exclusionary criteria are identical to our previous work; <10% of eligible mothers have been excluded.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Online PSST
An online version of Problem-Solving Skills Training (PSST) will be compared to standard (face-to-face) PSST
|
8-session manualized intervention to provide problem-solving skills training in the context of childhood cancer.
Other Names:
|
Active Comparator: Face-to-Face PSST
This is an 8-session face-to-face Problem-Solving Skills Training intervention
|
8-session manualized intervention to provide problem-solving skills training in the context of childhood cancer.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Social Problem Solving Skills Inventory
Time Frame: Baseline (T1), post intervention (3 months; T2), 3 months post intervention (6 months; T3)
|
This is a well validated assessment of problem-solving strategies and positive or negative orientation to problem solving.
|
Baseline (T1), post intervention (3 months; T2), 3 months post intervention (6 months; T3)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Profile of Mood States
Time Frame: Baseline (T1); post intervention (3 months; T2); 3 months post intervention (6 months; T3)
|
This is a well validated measure of depression and anxiety
|
Baseline (T1); post intervention (3 months; T2); 3 months post intervention (6 months; T3)
|
Patient Health Questionnaire (PHQ9)
Time Frame: Baseline (T1), post intervention (3 months; T2), 3 months post intervention (6 months; T3)
|
A 9-item self-administered version of the PRIME-MD diagnostic instrument for common mental disorders.
The PHQ9 is the depression module which rates each of the nine DSM-IV criteria as 0 (not at all) to 3 (nearly every day).
It will be used in place of the Beck Depression Inventory.
|
Baseline (T1), post intervention (3 months; T2), 3 months post intervention (6 months; T3)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Impact of Event Scale-Revised
Time Frame: Baseline (T1); post intervention (3 months; T2); 3 months post intervention (6 months; T3)
|
This is a well-validated assessment of the impact of a specified event (in this case, the diagnosis of cancer in a child)
|
Baseline (T1); post intervention (3 months; T2); 3 months post intervention (6 months; T3)
|
Bidimensional Acculturation Scale for Hispanics
Time Frame: Baseline (T1); post intervention (3 months; T2); 3 months post intervention (6 months; T3)
|
This is a well-validated measure of the degree to which an individual born in another country has adopted the customs of their new country
|
Baseline (T1); post intervention (3 months; T2); 3 months post intervention (6 months; T3)
|
Hispanic Stress Inventory
Time Frame: Baseline (T1); post intervention (3 months; T2); 3 months post intervention (6 months; T3)
|
This is a well validated assessment of the social, financial, and emotional ramifications associated with being a minority individual (in this case, Hispanic).
|
Baseline (T1); post intervention (3 months; T2); 3 months post intervention (6 months; T3)
|
Current Problems Inventory
Time Frame: Baseline (T1), post intervention (3 months; T2), 3 months post intervention (6 months; T3)
|
The Current Problems Inventory was developed by the investigators to provide examples of the kinds of problems commonly encountered in families with a child with cancer.
This form has been completed by participants at T1 in all studies of Bright IDEAS PSST to date.
During this project, the CPI will be given at T1, T2, and T3 to monitor change over time.
|
Baseline (T1), post intervention (3 months; T2), 3 months post intervention (6 months; T3)
|
Demographic Information
Time Frame: Baseline (T1)
|
Includes information about the child with cancer (age, diagnosis, date of diagnosis), parental age, marital status, educational level, occupational prestige of the family, and previous experience with the Internet.
|
Baseline (T1)
|
Impact of Event Scale-Revised (IES-R)
Time Frame: Baseline (T1), post intervention (3 months; T2), 3 months post intervention (6 months; T3)
|
A 22-item self-report measuring perceived post-traumatic stress, includes three subscales (intrusion, avoidance, and hyperarousal) that assess PTS symptoms (PTSSx) during the past week experienced in response to a specific event.
Widely used to measure PTSSx associated with events such as diagnosis with cancer.
Internal consistency reliabilities of the intrusion, avoidance, and hyperarousal subscales are .91,
.84,
and .90,
respectively.
|
Baseline (T1), post intervention (3 months; T2), 3 months post intervention (6 months; T3)
|
Credibility/Expectancy
Time Frame: After the first face-to-face PSST or ePSST session and after the fourth face-to-face PSST session or four weeks after the first ePSST session
|
Credibility is measured along four dimensions and expectancy is rated on a scale of 0 to 100.
These rating scales were developed by the investigators specifically for this purpose and used in our most recent previous study.
|
After the first face-to-face PSST or ePSST session and after the fourth face-to-face PSST session or four weeks after the first ePSST session
|
User Satisfaction
Time Frame: Post intervention (3 months; T2)
|
Will be assessed using a 21-item questionnaire developed by the investigators to address intervention-specific and website-specific issues.
Only the first five questions and the open-ended questions modified for the face-to-face group (specific to Bright IDEAS itself) will be completed by participants receiving the standard intervention.
The questionnaire will be administered at T2.
|
Post intervention (3 months; T2)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Olle Jane Z Sahler, MD, University of Rochester
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 1R01CA159013-01A1 (U.S. NIH Grant/Contract)
- R01CA159013-01A1 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Childhood Cancer
-
Australian & New Zealand Children's Haematology...Medical Research Future Fund; Minderoo Foundation; Children's Cancer Institute...RecruitingChildhood Cancer | Relapsed Cancer | Refractory Cancer | Childhood Leukemia | Childhood Solid Tumor | Childhood Brain TumorAustralia
-
University of Colorado, DenverRecruitingCancer | Childhood CancerUnited States
-
Children's Hospital of PhiladelphiaCompletedCancer | Childhood CancerUnited States
-
Sydney Children's Hospitals NetworkGerman Cancer Research Center; Australian & New Zealand Children's Haematology... and other collaboratorsActive, not recruitingChildhood Cancer | Relapsed Cancer | Refractory Cancer | Childhood Leukemia | Childhood Solid Tumor | Childhood Brain TumorAustralia
-
Wake Forest University Health SciencesTerminated
-
Gustave Roussy, Cancer Campus, Grand ParisActive, not recruiting
-
Pernille BidstrupOdense University Hospital; Aarhus University Hospital; Aarhus University Hospital... and other collaboratorsCompleted
-
Emory UniversityNational Cancer Institute (NCI)Recruiting
-
Children's Cancer Group, ChinaShanghai Children's Medical Center; Shanghai Municipal Center for Disease Prevention...Recruiting
-
St. Jude Children's Research HospitalRecruiting
Clinical Trials on Problem-Solving Skills Training
-
University of RochesterNational Institutes of Health (NIH)Completed
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)CompletedColo-rectal CancerUnited States
-
Seattle Children's HospitalOregon Health and Science UniversityCompletedChronic Pain | Abdominal Pain | HeadacheUnited States
-
US Department of Veterans AffairsCompleted
-
University of PennsylvaniaNational Heart, Lung, and Blood Institute (NHLBI); Drexel UniversityCompleted
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Dartmouth-Hitchcock Medical CenterNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Family Conflict | Perinatal DepressionUnited States
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Coronary Disease | Diabetes Mellitus, Type 2United States
-
RANDCompleted
-
Atatürk UniversityPhd Nurgül KarakurtCompletedChild Development Disorders, Pervasive | Mother-Infant Interaction | Problems PsychosocialTurkey